Pharmacokinetics and tolerability of two different formulations of budesonide/formoterol (160/4.5 and 200/6 microg, respectively; administered via either the Spiromax or Turbuhaler device), with and without charcoal, in volunteers
Latest Information Update: 21 Oct 2015
At a glance
- Drugs Budesonide/formoterol (Primary) ; Budesonide/formoterol (Primary) ; Charcoal
- Indications Asthma
- Focus Pharmacokinetics
- 31 Oct 2013 New trial record
- 11 Sep 2013 Results presented at the 23rd Annual Congress of the European Respiratory Society.